Search research articles
Contact Us
Filters
Showing results (391-400 of 606) with videos related to
Page
of 61
Sort By:
Synapse (New York, N.Y.)
|
February 1, 1995
6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptors
H Xu, C B Goodman, J S Partilla, et al.
Peptides
|
January 1, 1994
Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors
R B Raffa, A Kim, K C Rice, et al.
Pharmacology, Biochemistry, and Behavior
|
December 1, 1992
Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter
R B Rothman, N Grieg, A Kim, et al.
Synapse (New York, N.Y.)
|
April 3, 1999
Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans
V L Villemagne, R B Rothman, F Yokoi, et al.
Journal of Medicinal Chemistry
|
May 7, 1999
delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole
A Coop, R B Rothman, C Dersch, et al.
Synapse (New York, N.Y.)
|
October 1, 1995
Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice
J L Cadet, B Ladenheim, H Hirata, et al.
Peptides
|
January 1, 1991
Upregulation of the opioid receptor complex by the chronic administration of morphine: a biochemical marker related to the development of tolerance and dependence
R B Rothman, J B Long, V Bykov, et al.
FEBS Letters
|
November 6, 1989
Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development
R B Rothman, A Mele, A A Reid, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 20, 2015
Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency
Richard B Rothman, Subramaniam Ananthan, John S Partilla, et al.
Life Sciences
|
January 1, 1991
RTI-4614-4: an analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites
R B Rothman, H Xu, M Seggel, et al.
Page
of 61
Search research articles
Search
Showing results (391-400 of 606) with videos related to
Sort By:
Page
of 61
Synapse (New York, N.Y.)
|
February 1, 1995
6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptors
H Xu, C B Goodman, J S Partilla, et al.
Peptides
|
January 1, 1994
Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors
R B Raffa, A Kim, K C Rice, et al.
Pharmacology, Biochemistry, and Behavior
|
December 1, 1992
Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter
R B Rothman, N Grieg, A Kim, et al.
Synapse (New York, N.Y.)
|
April 3, 1999
Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans
V L Villemagne, R B Rothman, F Yokoi, et al.
Journal of Medicinal Chemistry
|
May 7, 1999
delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole
A Coop, R B Rothman, C Dersch, et al.
Synapse (New York, N.Y.)
|
October 1, 1995
Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice
J L Cadet, B Ladenheim, H Hirata, et al.
Peptides
|
January 1, 1991
Upregulation of the opioid receptor complex by the chronic administration of morphine: a biochemical marker related to the development of tolerance and dependence
R B Rothman, J B Long, V Bykov, et al.
FEBS Letters
|
November 6, 1989
Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development
R B Rothman, A Mele, A A Reid, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 20, 2015
Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency
Richard B Rothman, Subramaniam Ananthan, John S Partilla, et al.
Life Sciences
|
January 1, 1991
RTI-4614-4: an analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites
R B Rothman, H Xu, M Seggel, et al.
Page
of 61